ophthalmology Archives - Pharmaphorum

ophthalmology

Astellas buys eye gene therapy biotech Quethera for $109m

https://pharmaphorum.com/news/astellas-expands-ocular-gene-therapy-investment/

Industry news with an exclusive interview by from Aerie Pharmaceuticals

https://pharmaphorum.com/partner-content/industry-news-with-an-exclusive-interview-by-from-aerie-pharmaceuticals/

Gene Therapy bringing new hope to patients and families

https://pharmaphorum.com/partner-content/gene-therapy-bringing-new-hope-to-patients-and-families/

Exclusive Interview Released from Santen for Ophthalmic Drugs 2018

https://pharmaphorum.com/partner-content/exclusive-interview-released-from-santen-for-ophthalmic-drugs-2018/

Your Latest Ophthalmology News for SMi’s Ophthalmic Drugs 2018

https://pharmaphorum.com/partner-content/your-latest-ophthalmology-news-for-smis-ophthalmic-drugs-2018/

Explore New Strategies for Treating Retinal Vascular Disease Ophthalmic Drugs 2018

https://pharmaphorum.com/partner-content/explore-new-strategies-for-treating-retinal-vascular-disease-ophthalmic-drugs-2018/

Explore the future of ocular gene editing and strategic drug delivery

https://pharmaphorum.com/partner-content/explore-the-future-of-ocular-gene-editing-and-strategic-drug-delivery/

Ophthalmic Drugs 2018

https://pharmaphorum.com/events/ophthalmic-drugs-2018/

Priority review voucher prices fall again after Spark’s $110m sale

https://pharmaphorum.com/news/spark-sells-priority-review-voucher-to-jazz/

Search